Li X - Search Results

1

Apatinib plus docetaxel or pemetrexed shows promising activities against non-small cell lung cancer with brain metastasis: a retrospective analysis.

Tang J, Jiang H, Xiang Z, Zhu X, Xie R, Wu D, Peng L, Li X. Tang J, et al. Among authors: li x. J Thorac Dis. 2024 Jan 30;16(1):615-622. doi: 10.21037/jtd-23-1860. Epub 2024 Jan 22. J Thorac Dis. 2024. PMID: 38410538 Free PMC article.

2

The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.

Li X, Wu D, Tang J, Wu Y. Li X, et al. J Cancer Res Clin Oncol. 2024 May 23;150(5):271. doi: 10.1007/s00432-024-05808-0. J Cancer Res Clin Oncol. 2024. PMID: 38780840 Free PMC article.

3

The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2^nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study.

Li X, Wu D, Tang J, Wu Y. Li X, et al. Cancer Manag Res. 2024 Aug 8;16:1003-1012. doi: 10.2147/CMAR.S472196. eCollection 2024. Cancer Manag Res. 2024. PMID: 39135711 Free PMC article.

4

Efficacy and safety of anlotinib as maintenance therapy in patients with advanced non-small cell lung cancer achieving SD post first-line chemotherapy combined with immunotherapy.

Li X, Peng Y, Wu D, Tang J, Wu Y. Li X, et al. J Chemother. 2024 Sep 1:1-9. doi: 10.1080/1120009X.2024.2397924. Online ahead of print. J Chemother. 2024. PMID: 39219263

5

Albumin bound-paclitaxel combined with anlotinib and immunotherapy in the second-line treatment of ES-SCLC: a retrospective cohort study.

Li X, Wu D, Tang J, Wu Y. Li X, et al. Neoplasma. 2024 Oct;71(5):482-489. doi: 10.4149/neo_2024_240716N299. Neoplasma. 2024. PMID: 39556427

6

The Efficacy and Safety of Albumin-Bound Paclitaxel Combined With Anlotinib and PD-1/L1 Inhibitors For Treating Patients With Extensive-Stage Small Cell Lung Cancer and Brain Metastasis: A Retrospective Cohort Study.

Li X, Wu D, Peng Y, Tang J, Wu Y. Li X, et al. Cancer Med. 2024 Dec;13(23):e70449. doi: 10.1002/cam4.70449. Cancer Med. 2024. PMID: 39660471 Free PMC article.

7

A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by Sulfated Glycosaminoglycan Derivatives.

Pang J, Zhu D, Liu Y, Liu D, Zhao C, Zhang J, Li S, Liu Z, Li X, Huang P, Wen S, Yang J. Pang J, et al. Among authors: li s, li x. Adv Healthc Mater. 2023 Jul;12(17):e2203011. doi: 10.1002/adhm.202203011. Epub 2023 Mar 16. Adv Healthc Mater. 2023. PMID: 36841552

8

Pregnane C21-Steroids with Anti-inflammatory Activity from the Roots of Cynanchum bungei.

Li X, Li XS, Zhang AL, Yuan WB, Feng WB, Zheng TX, Cai HT, Lin ZX, Zhang YB, Lan CY, Yan C. Li X, et al. Among authors: li xs. Chem Biodivers. 2025 Jan 6:e202403412. doi: 10.1002/cbdv.202403412. Online ahead of print. Chem Biodivers. 2025. PMID: 39761037

9

The Effects of Compound Starter Culture and Sugar and Soy Milk on the Quality and Probiotic Activity of Milk-Soy Mixed Yogurt.

Jiang W, Han S, Wang L, Li X. Jiang W, et al. Among authors: li x. J AOAC Int. 2025 Jan 6:qsaf001. doi: 10.1093/jaoacint/qsaf001. Online ahead of print. J AOAC Int. 2025. PMID: 39760883

10

ASO Visual Abstract: Ultrasound Visualization of the Recurrent Laryngeal Nerve-A Prospective Clinical Validation Study.

Yao XY, Li X, Yu B, Liu SR, Wang BY, Lu SY, Li HW, Song SB, Cui LG, Tan S. Yao XY, et al. Among authors: li x. Ann Surg Oncol. 2025 Jan 6. doi: 10.1245/s10434-024-16694-8. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39760801 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,959 results

Search Page

Filters